Pediatric cinnarizine overdose and toxicokinetics

Pediatrics

Volumn 117, Issue 5, 2006, Pages

  Turner, Dan ^a,d   Lurie, Yael ^b   Finkelstein, Yoram ^a   Schmid, Tal ^a   Gopher, Asher ^c   Kleid, David ^a   Bentur, Yedidia ^b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cinnarizine; Intoxication; Overdose; Poisoning; Toddler; Toxicokinetics

Indexed keywords

CINNARIZINE; MIDAZOLAM;

ARTICLE; BLOOD SAMPLING; CASE REPORT; CHILD; CLONIC SEIZURE; CONSCIOUSNESS DISORDER; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MUSCLE HYPOTONIA; NERVOUSNESS; NEUROLOGIC DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; TERATOGENICITY; VOMITING; CHEMICALLY INDUCED DISORDER; COMA; HOME ACCIDENT; PRESCHOOL CHILD; SEIZURE;

ACCIDENTS, HOME; CHILD, PRESCHOOL; CINNARIZINE; COMA; FEMALE; HUMANS; SEIZURES;

EID: 33646841802     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2059     Document Type: Article

References (16)

1. Masso JFM, Obeso JA, Carrera N, Martinez-Lage JM. Aggravation of Parkinson's disease by cinnarizine. J Neurol Neurosurg Psychiatry. 1987;50:804-805
2. Godfraind T. Classification of calcium antagonists. Am J Cardiol. 1987;59:11B-23B
3. Thomas RJ. Seizures and epilepsy in the elderly. Arch Intern Med. 1997;157:605-617
4. Okoro EO, Marwood JF. Effects of 5HT2 receptor antagonists on responses to potassium depolarization in rat isolated aorta. Clin Exp Pharmacol Physiol. 1997;24:34-39
5. Micheli F, Pardel MF, Gatto M, et al. Flunarizine and cinnarizine induced extrapyramidal reactions. Neurology. 1987;37:881-884
6. Nicholson AN, Stone BM, Turner C, Mills SL. Central effects of cinnarizine: restricted use in aircrew. Aviat Space Environ Med. 2002;73:570-574
7. Cinnarizine. In: Drugdex, Healthcare Series. Vol 123. Greenwood Village, CO: Thomson-Micromedex; 2005
8. Moss SF, Walker RF, Tonge KA. Cholestasis associated with cinnarizine. BMJ. 1990;301:1281-1281
9. Castaneda-Hernandez G, Vargas-Alvarado Y, Aguirre F, Flores-Murrieta FJ. Pharmacokinetics of cinnarizine after single and multiple dosing in healthy volunteers. Arzneimittelforschung. 1993;43:539-542
10. Morrison PJ, Bradbrook ID, Rogers HJ. Plasma cinnarizine levels resulting from oral administration as capsule or tablet formulation investigated by gas-liquid chromatography. Br J Clin Pharmacol. 1979;7:349-352
11. Radovanovic D, Meier PJ, Guirguis M, Lorent JP, Kupferschmidt H. Dose-dependent toxicity of diphenhydramine overdose. Hum Exp Toxicol. 2000;19:489-495
12. Olson KR, Kearney TE, Dyer JE, Benowitz NL, Blanc PD. Seizures associated with poisoning and drug overdose. Am J Emerg Med. 1993;11:565-568
13. Yasuhara A, Ochi A, Harada Y, Kobayashi Y. Infantile spasms associated with a histamine H1 antagonist. Neuropediatrics. 1998;29:320-321
14. Estelle R, Simons R. H1-receptor antagonists. Comparative tolerability and safety. Drug Saf. 1994;10:350-380
15. Mena MA, Garcia de Yebenes MJ, Tabernero C, Casarejos MJ, Pardo B, Garcia de Yebenes J. Effects of calcium antagonists on the dopamine system. Clin Neuropharmacol. 1995;18:410-426
16. Phenothiazines. In: Poisindex, Healthcare Series. Vol 123. Greenwood Village, CO: Thomson-Micromedex; 2005